Launch of the Discoveries Centre for Regenerative and Precision Medicine
5 February 2018
Friends, funders and colleagues gathered at UCL yesterday to celebrate the launch of a multi-site venture aimed at enhancing regenerative medicine research in Portugal.
The new Centre will focus on three clinical areas: musculoskeletal, cardiovascular and neurodegenerative disorders.
Professor Knowles said: “We are delighted to be able to launch the centre in collaboration with our partner in the Portuguese Universities.
“It will play a key role in the search for new and innovative strategies and interventions to tackle a wide range of diseases.
“The UCL Team will now focus on developing its translational capabilities both from a clinical and entrepreneurial perspective.”
Yesterday’s event featured a number of talks from stakeholders and was followed by a drinks reception.
Find out more about the Centre
Pictured [L-R]: Professor John Martin, Professor Rui Reis, UCL Vice-Provost Health Professor David Lomas, Professor Jonathan Knowles
An Introduction to the Discoveries Centre for Regenerative and Precision Medicine Professor Rui Reis, Vice-Rector for Research & Innovation, University of Minho
UCL & The Discoveries Centre for Regenerative and Precision Medicine Professor Jonathan Knowles, Head of the Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute
Breaking down barriers in translation Dr Jane Kinghorn, Director, UCL Translational Research Office
From Bench to Bedside: translational orthopaedic research at the RNOH Professor John Skinner, Director of Research and Development, Royal National Orthopaedic Hospital NHS Trust
Developing a gene therapy for Duchenne muscular dystrophy Professor Thomas Voit, Director, NIHR GOSH Biomedical Research Centre
Increasing the odds of drug development success using human genomics Professor Aroon Hingorani, Director of the UCL Institute of Cardiovascular Science and Professor of Genetic Epidemiology
This project has received funding from the European Union's Horizon 2020 research and innovation programme, under grant agreement No 739572.